Full Coverage

Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals' Nicotinic...

                   
prnewswire.com
May 2, 2008
        
Story Timeline:  217 days

Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals' Nicotinic Alpha-7 Agonist, MEM 3454 -Memory Receives $6 Million Milestone Payment- -Memory to Host Conference Call at 9:00 a.m. EDT Today- Memory Pharmaceuticals Corp. (Nasdaq: MEMY)... [read full story]                    

Add Comment
Latest article on this story:

OTCPicks.com: OTCPicks.com Daily Market Movers Digest Midday Report for Friday, May 2nd MGRN,...

 tmcnet.com May 2, 2008
First article on this story:

OTCPicks.com: OTCPicks.com Daily Market Movers Digest Midday Report for Friday, May 2nd MGRN,...

 tmcnet.com May 2, 2008
Selected publications with coverage of this story:
prnewswire.com tmcnet.com
RELATED
Found 1 documents:
                   

OTCPicks.com: OTCPicks.com Daily Market Movers Digest Midday Report for Friday, May 2nd MGRN,...

tmcnet.com
May 2, 2008
        

OTCPicks.com: OTCPicks.com Daily Market Movers Digest Midday Report for Friday, May 2nd MGRN, PIII, EXPT, MEMY, TRXI ... Our Stocks to Watch today include Monogram Energy Inc. (OTC: MGRN), PECO II Inc. (NASD: PIII), Expert Group Inc. (OTC: EXPT), Memory Pharmaceuticals...